ROCKVILLE, Md., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced that Company’s Management will provide a corporate update and participate in one-on-one investor meetings at the the B. Riley Securities 3rd Annual Oncology Conference, to be held virtually from January 18-19, 2023.
The rest is here:
Theriva Biologics to Participate in the B. Riley Securities 3rd Annual Oncology Conference
Recommendation and review posted by Fredricko
